Metraipolis › archive › dc_e00e632aa511

Genome agnostic, multi-level non-oncogene addiction-based systems pharmacology for rescuing metastatic relapsed/refractory neoplasias — Europe PMC PMID:41815915

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41815915
DOI
10.3389/fphar.2026.1629187
License (as archived)
solo-consultazione
Archived
2026-11-05T13:13:44.954Z
SHA-256 of the archived text
1c2f55753de3e32378e8aef79a9d45bf5bb1f79933c7bbdaf9f81764ff154731
Stable URL of this page
https://metraipolis.com/documento/dc_e00e632aa511

How to cite

Genome agnostic, multi-level non-oncogene addiction-based systems pharmacology for rescuing metastatic relapsed/refractory neoplasias — Europe PMC PMID:41815915 — Europe PMC (en), https://europepmc.org/article/MED/41815915 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e00e632aa511 (Metraipolis archive dc_e00e632aa511, sha256 1c2f55753de3e32378e8aef79a9d45bf5bb1f79933c7bbdaf9f81764ff154731)
BibTeX
@misc{dce00e632aa511,
  title = {Genome agnostic, multi-level non-oncogene addiction-based systems pharmacology for rescuing metastatic relapsed/refractory neoplasias — Europe PMC PMID:41815915},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41815915},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e00e632aa511; sha256 1c2f55753de3e32378e8aef79a9d45bf5bb1f79933c7bbdaf9f81764ff154731},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41815915. Agents can read the archived copy with the MCP tool read_document.